A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes

This study has been completed.
Sponsor:
Collaborator:
People's Liberation Army General Hospital of Chengdu Military Region
Information provided by (Responsible Party):
Jiangsu HengRui Medicine Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01965496
First received: June 12, 2013
Last updated: October 15, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)